Selected research
Market Outlook & Growth Opportunities
Global Long Read Sequencing Market Outlook and Growth Opportunities 2026
Market perspective
The global Long Read Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Long Read Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Long Read Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Long Read Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Long Read Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Long Read Sequencing market include Oxford Nanopore Technologies, Pacific Biosciences of California, BaseClear B.V., Future Genomics Technologies, Garvan Institute of Medical Research, Genome Transcriptome Facility of Bordeaux, NextOmics, Takara Bio and Quantapore, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Long Read Sequencing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Long Read Sequencing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Long Read Sequencing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Long Read Sequencing market.
Long Read Sequencing Segment by Company
Oxford Nanopore Technologies
Pacific Biosciences of California
BaseClear B.V.
Future Genomics Technologies
Garvan Institute of Medical Research
Genome Transcriptome Facility of Bordeaux
NextOmics
Takara Bio
Quantapore
Roche
MicrobesNG
Institute of Integrative Biology of the Cell
Long Read Sequencing Segment by Type
Consumables
Instruments
Services
Long Read Sequencing Segment by Application
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Other
Long Read Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Long Read Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Long Read Sequencing key companies, revenue, market share, and recent developments.
3. To split the Long Read Sequencing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Long Read Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Long Read Sequencing significant trends, drivers, influence factors in global and regions.
6. To analyze Long Read Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long Read Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Long Read Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long Read Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Long Read Sequencing industry.
Chapter 3: Detailed analysis of Long Read Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Long Read Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Long Read Sequencing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Long Read Sequencing Industry Trends
Table 2. Long Read Sequencing Industry Drivers
Table 3. Long Read Sequencing Industry Opportunities and Challenges
Table 4. Long Read Sequencing Industry Restraints
Table 5. Global Long Read Sequencing Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Long Read Sequencing Revenue Share by Company (2021-2026)
Table 7. Global Long Read Sequencing Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Long Read Sequencing Key Company Manufacturing Base & Headquarters
Table 9. Global Long Read Sequencing Company, Product Type & Application
Table 10. Global Long Read Sequencing Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Long Read Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Consumables
Table 15. Significant Companies of Instruments
Table 16. Significant Companies of Services
Table 17. Global Long Read Sequencing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 18. Global Long Read Sequencing Sales Value by Type (2021-2026) & (US$ Million)
Table 19. Global Long Read Sequencing Sales Value by Type (2027-2032) & (US$ Million)
Table 20. Global Long Read Sequencing Sales Value Share by Type (2021-2026)
Table 21. Global Long Read Sequencing Sales Value Share by Type (2027-2032)
Table 22. Significant Companies of Academic Research
Table 23. Significant Companies of Clinical Research
Table 24. Significant Companies of Hospitals & Clinics
Table 25. Significant Companies of Pharma & Biotech Entities
Table 26. Significant Companies of Other
Table 27. Global Long Read Sequencing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 28. Global Long Read Sequencing Sales Value by Application (2021-2026) & (US$ Million)
Table 29. Global Long Read Sequencing Sales Value by Application (2027-2032) & (US$ Million)
Table 30. Global Long Read Sequencing Sales Value Share by Application (2021-2026)
Table 31. Global Long Read Sequencing Sales Value Share by Application (2027-2032)
Table 32. Global Long Read Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 33. Global Long Read Sequencing Sales Value by Region (2021-2026) & (US$ Million)
Table 34. Global Long Read Sequencing Sales Value Share by Region (2021-2026)
Table 35. Global Long Read Sequencing Sales Value by Region (2027-2032) & (US$ Million)
Table 36. Global Long Read Sequencing Sales Value Share by Region (2027-2032)
Table 37. Global Long Read Sequencing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 38. Global Long Read Sequencing Sales Value by Country (2021-2026) & (US$ Million)
Table 39. Global Long Read Sequencing Sales Value Market Share by Country (2021-2026)
Table 40. Global Long Read Sequencing Sales Value by Country (2027-2032) & (US$ Million)
Table 41. Global Long Read Sequencing Sales Value Market Share by Country (2027-2032)
Table 42. Oxford Nanopore Technologies Company Information
Table 43. Oxford Nanopore Technologies Business Overview
Table 44. Oxford Nanopore Technologies Long Read Sequencing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 45. Oxford Nanopore Technologies Long Read Sequencing Product Portfolio
Table 46. Oxford Nanopore Technologies Recent Development
Table 47. Pacific Biosciences of California Company Information
Table 48. Pacific Biosciences of California Business Overview
Table 49. Pacific Biosciences of California Long Read Sequencing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 50. Pacific Biosciences of California Long Read Sequencing Product Portfolio
Table 51. Pacific Biosciences of California Recent Development
Table 52. BaseClear B.V. Company Information
Table 53. BaseClear B.V. Business Overview
Table 54. BaseClear B.V. Long Read Sequencing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 55. BaseClear B.V. Long Read Sequencing Product Portfolio
Table 56. BaseClear B.V. Recent Development
Table 57. Future Genomics Technologies Company Information
Table 58. Future Genomics Technologies Business Overview
Table 59. Future Genomics Technologies Long Read Sequencing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 60. Future Genomics Technologies Long Read Sequencing Product Portfolio
Table 61. Future Genomics Technologies Recent Development
Table 62. Garvan Institute of Medical Research Company Information
Table 63. Garvan Institute of Medical Research Business Overview
Table 64. Garvan Institute of Medical Research Long Read Sequencing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. Garvan Institute of Medical Research Long Read Sequencing Product Portfolio
Table 66. Garvan Institute of Medical Research Recent Development
Table 67. Genome Transcriptome Facility of Bordeaux Company Information
Table 68. Genome Transcriptome Facility of Bordeaux Business Overview
Table 69. Genome Transcriptome Facility of Bordeaux Long Read Sequencing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 70. Genome Transcriptome Facility of Bordeaux Long Read Sequencing Product Portfolio
Table 71. Genome Transcriptome Facility of Bordeaux Recent Development
Table 72. NextOmics Company Information
Table 73. NextOmics Business Overview
Table 74. NextOmics Long Read Sequencing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 75. NextOmics Long Read Sequencing Product Portfolio
Table 76. NextOmics Recent Development
Table 77. Takara Bio Company Information
Table 78. Takara Bio Business Overview
Table 79. Takara Bio Long Read Sequencing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Takara Bio Long Read Sequencing Product Portfolio
Table 81. Takara Bio Recent Development
Table 82. Quantapore Company Information
Table 83. Quantapore Business Overview
Table 84. Quantapore Long Read Sequencing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 85. Quantapore Long Read Sequencing Product Portfolio
Table 86. Quantapore Recent Development
Table 87. Roche Company Information
Table 88. Roche Business Overview
Table 89. Roche Long Read Sequencing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 90. Roche Long Read Sequencing Product Portfolio
Table 91. Roche Recent Development
Table 92. MicrobesNG Company Information
Table 93. MicrobesNG Business Overview
Table 94. MicrobesNG Long Read Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 95. MicrobesNG Long Read Sequencing Product Portfolio
Table 96. MicrobesNG Recent Development
Table 97. Institute of Integrative Biology of the Cell Company Information
Table 98. Institute of Integrative Biology of the Cell Business Overview
Table 99. Institute of Integrative Biology of the Cell Long Read Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 100. Institute of Integrative Biology of the Cell Long Read Sequencing Product Portfolio
Table 101. Institute of Integrative Biology of the Cell Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Authors List of This Report
Table 104. Secondary Sources
Table 105. Primary Sources
List of Figures
Figure 1. Long Read Sequencing Product Image
Figure 2. Global Long Read Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Long Read Sequencing Market Size (2021-2032) & (US$ Million)
Figure 4. Global Long Read Sequencing Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Consumables Image
Figure 8. Instruments Image
Figure 9. Services Image
Figure 10. Global Long Read Sequencing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Long Read Sequencing Sales Value Share 2021 VS 2025 VS 2032
Figure 12. Global Long Read Sequencing Sales Value Share by Type (2021-2032)
Figure 13. Academic Research Image
Figure 14. Clinical Research Image
Figure 15. Hospitals & Clinics Image
Figure 16. Pharma & Biotech Entities Image
Figure 17. Other Image
Figure 18. Global Long Read Sequencing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 19. Global Long Read Sequencing Sales Value Share 2021 VS 2025 VS 2032
Figure 20. Global Long Read Sequencing Sales Value Share by Application (2021-2032)
Figure 21. Global Long Read Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 22. Global Long Read Sequencing Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 23. North America Long Read Sequencing Sales Value (2021-2032) & (US$ Million)
Figure 24. North America Long Read Sequencing Sales Value Share by Country (%), 2025 VS 2032
Figure 25. Europe Long Read Sequencing Sales Value (2021-2032) & (US$ Million)
Figure 26. Europe Long Read Sequencing Sales Value Share by Country (%), 2025 VS 2032
Figure 27. Asia-Pacific Long Read Sequencing Sales Value (2021-2032) & (US$ Million)
Figure 28. Asia-Pacific Long Read Sequencing Sales Value Share by Country (%), 2025 VS 2032
Figure 29. South America Long Read Sequencing Sales Value (2021-2032) & (US$ Million)
Figure 30. South America Long Read Sequencing Sales Value Share by Country (%), 2025 VS 2032
Figure 31. Middle East & Africa Long Read Sequencing Sales Value (2021-2032) & (US$ Million)
Figure 32. Middle East & Africa Long Read Sequencing Sales Value Share by Country (%), 2025 VS 2032
Figure 33. USA Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 34. USA Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 35. USA Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 36. Canada Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. Canada Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. Canada Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Mexico Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Mexico Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Mexico Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. Germany Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. Germany Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. Germany Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. France Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. France Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. France Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. U.K. Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. U.K. Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. U.K. Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Italy Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Italy Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Italy Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Spain Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Spain Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Spain Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Russia Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Russia Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Russia Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Netherlands Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Netherlands Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Netherlands Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. Nordic Countries Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. Nordic Countries Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. Nordic Countries Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. China Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. China Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. China Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. Japan Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. Japan Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. Japan Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. South Korea Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. South Korea Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. South Korea Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. India Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. India Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. India Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Australia Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Australia Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Australia Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Southeast Asia Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Southeast Asia Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Southeast Asia Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Brazil Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Brazil Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Brazil Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Argentina Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Argentina Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Argentina Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Chile Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Chile Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Chile Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Colombia Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Colombia Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Colombia Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Peru Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Peru Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Peru Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Saudi Arabia Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Saudi Arabia Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Saudi Arabia Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. Israel Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. Israel Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. Israel Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. UAE Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. UAE Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. UAE Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Turkey Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Turkey Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Turkey Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Iran Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Iran Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Iran Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Egypt Long Read Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 115. Egypt Long Read Sequencing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 116. Egypt Long Read Sequencing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 117. Years Considered
Figure 118. Research Process
Figure 119. Key Executives Interviewed
Scope & coverage.
Types
- Consumables
- Instruments
- Services
Applications
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other
Companies covered
- Oxford Nanopore Technologies
- Pacific Biosciences of California
- BaseClear B.V.
- Future Genomics Technologies
- Garvan Institute of Medical Research
- Genome Transcriptome Facility of Bordeaux
- NextOmics
- Takara Bio
- Quantapore
- Roche
- MicrobesNG
- Institute of Integrative Biology of the Cell
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Long Read Sequencing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Long Read Sequencing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Long Read Sequencing Market Dynamics
- 2.1 Long Read Sequencing Industry Trends
- 2.2 Long Read Sequencing Industry Drivers
- 2.3 Long Read Sequencing Industry Opportunities and Challenges
- 2.4 Long Read Sequencing Industry Restraints
3 Long Read Sequencing Market by Company
- 3.1 Global Long Read Sequencing Company Revenue Ranking in 2025
- 3.2 Global Long Read Sequencing Revenue by Company (2021-2026)
- 3.3 Global Long Read Sequencing Company Ranking (2024-2026)
- 3.4 Global Long Read Sequencing Company Manufacturing Base and Headquarters
- 3.5 Global Long Read Sequencing Company Product Type and Application
- 3.6 Global Long Read Sequencing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Long Read Sequencing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Long Read Sequencing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Long Read Sequencing Market by Type
- 4.1 Long Read Sequencing Type Introduction
- 4.1.1 Consumables
- 4.1.2 Instruments
- 4.1.3 Services
- 4.2 Global Long Read Sequencing Sales Value by Type
- 4.2.1 Global Long Read Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Long Read Sequencing Sales Value by Type (2021-2032)
- 4.2.3 Global Long Read Sequencing Sales Value Share by Type (2021-2032)
5 Long Read Sequencing Market by Application
- 5.1 Long Read Sequencing Application Introduction
- 5.1.1 Academic Research
- 5.1.2 Clinical Research
- 5.1.3 Hospitals & Clinics
- 5.1.4 Pharma & Biotech Entities
- 5.1.5 Other
- 5.2 Global Long Read Sequencing Sales Value by Application
- 5.2.1 Global Long Read Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Long Read Sequencing Sales Value by Application (2021-2032)
- 5.2.3 Global Long Read Sequencing Sales Value Share by Application (2021-2032)
6 Long Read Sequencing Regional Value Analysis
- 6.1 Global Long Read Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Long Read Sequencing Sales Value by Region (2021-2032)
- 6.2.1 Global Long Read Sequencing Sales Value by Region: 2021-2026
- 6.2.2 Global Long Read Sequencing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Long Read Sequencing Sales Value (2021-2032)
- 6.3.2 North America Long Read Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Long Read Sequencing Sales Value (2021-2032)
- 6.4.2 Europe Long Read Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Long Read Sequencing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Long Read Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Long Read Sequencing Sales Value (2021-2032)
- 6.6.2 South America Long Read Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Long Read Sequencing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Long Read Sequencing Sales Value Share by Country, 2025 VS 2032
7 Long Read Sequencing Country-level Value Analysis
- 7.1 Global Long Read Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Long Read Sequencing Sales Value by Country (2021-2032)
- 7.2.1 Global Long Read Sequencing Sales Value by Country (2021-2026)
- 7.2.2 Global Long Read Sequencing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Long Read Sequencing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Long Read Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Long Read Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Oxford Nanopore Technologies
- 8.1.1 Oxford Nanopore Technologies Company Information
- 8.1.2 Oxford Nanopore Technologies Business Overview
- 8.1.3 Oxford Nanopore Technologies Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.1.4 Oxford Nanopore Technologies Long Read Sequencing Product Portfolio
- 8.1.5 Oxford Nanopore Technologies Recent Developments
- 8.2 Pacific Biosciences of California
- 8.2.1 Pacific Biosciences of California Company Information
- 8.2.2 Pacific Biosciences of California Business Overview
- 8.2.3 Pacific Biosciences of California Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.2.4 Pacific Biosciences of California Long Read Sequencing Product Portfolio
- 8.2.5 Pacific Biosciences of California Recent Developments
- 8.3 BaseClear B.V.
- 8.3.1 BaseClear B.V. Company Information
- 8.3.2 BaseClear B.V. Business Overview
- 8.3.3 BaseClear B.V. Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.3.4 BaseClear B.V. Long Read Sequencing Product Portfolio
- 8.3.5 BaseClear B.V. Recent Developments
- 8.4 Future Genomics Technologies
- 8.4.1 Future Genomics Technologies Company Information
- 8.4.2 Future Genomics Technologies Business Overview
- 8.4.3 Future Genomics Technologies Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.4.4 Future Genomics Technologies Long Read Sequencing Product Portfolio
- 8.4.5 Future Genomics Technologies Recent Developments
- 8.5 Garvan Institute of Medical Research
- 8.5.1 Garvan Institute of Medical Research Company Information
- 8.5.2 Garvan Institute of Medical Research Business Overview
- 8.5.3 Garvan Institute of Medical Research Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.5.4 Garvan Institute of Medical Research Long Read Sequencing Product Portfolio
- 8.5.5 Garvan Institute of Medical Research Recent Developments
- 8.6 Genome Transcriptome Facility of Bordeaux
- 8.6.1 Genome Transcriptome Facility of Bordeaux Company Information
- 8.6.2 Genome Transcriptome Facility of Bordeaux Business Overview
- 8.6.3 Genome Transcriptome Facility of Bordeaux Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.6.4 Genome Transcriptome Facility of Bordeaux Long Read Sequencing Product Portfolio
- 8.6.5 Genome Transcriptome Facility of Bordeaux Recent Developments
- 8.7 NextOmics
- 8.7.1 NextOmics Company Information
- 8.7.2 NextOmics Business Overview
- 8.7.3 NextOmics Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.7.4 NextOmics Long Read Sequencing Product Portfolio
- 8.7.5 NextOmics Recent Developments
- 8.8 Takara Bio
- 8.8.1 Takara Bio Company Information
- 8.8.2 Takara Bio Business Overview
- 8.8.3 Takara Bio Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.8.4 Takara Bio Long Read Sequencing Product Portfolio
- 8.8.5 Takara Bio Recent Developments
- 8.9 Quantapore
- 8.9.1 Quantapore Company Information
- 8.9.2 Quantapore Business Overview
- 8.9.3 Quantapore Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.9.4 Quantapore Long Read Sequencing Product Portfolio
- 8.9.5 Quantapore Recent Developments
- 8.10 Roche
- 8.10.1 Roche Company Information
- 8.10.2 Roche Business Overview
- 8.10.3 Roche Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.10.4 Roche Long Read Sequencing Product Portfolio
- 8.10.5 Roche Recent Developments
- 8.11 MicrobesNG
- 8.11.1 MicrobesNG Company Information
- 8.11.2 MicrobesNG Business Overview
- 8.11.3 MicrobesNG Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.11.4 MicrobesNG Long Read Sequencing Product Portfolio
- 8.11.5 MicrobesNG Recent Developments
- 8.12 Institute of Integrative Biology of the Cell
- 8.12.1 Institute of Integrative Biology of the Cell Company Information
- 8.12.2 Institute of Integrative Biology of the Cell Business Overview
- 8.12.3 Institute of Integrative Biology of the Cell Long Read Sequencing Revenue and Gross Margin (2021-2026)
- 8.12.4 Institute of Integrative Biology of the Cell Long Read Sequencing Product Portfolio
- 8.12.5 Institute of Integrative Biology of the Cell Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst